Amanda Louise Murphy - Nov 12, 2021 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Signature
/s/ Brian F. Leaf, attorney-in-fact
Stock symbol
MXCT
Transactions as of
Nov 12, 2021
Transactions value $
-$1,183,567
Form type
4
Date filed
11/16/2021, 06:12 PM
Previous filing
Aug 11, 2021
Next filing
Mar 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Options Exercise $226K +51.1K $4.42 51.1K Nov 12, 2021 Direct F1
transaction MXCT Common Stock Sale -$647K -51.1K -100% $12.66 0 Nov 12, 2021 Direct F2
transaction MXCT Common Stock Options Exercise $272K +61.6K $4.42 61.6K Nov 15, 2021 Direct F1
transaction MXCT Common Stock Sale -$749K -61.6K -100% $12.16 0 Nov 15, 2021 Direct F3
transaction MXCT Common Stock Options Exercise $165K +37.3K $4.42 37.3K Nov 16, 2021 Direct F1
transaction MXCT Common Stock Sale -$451K -37.3K -100% $12.08 0 Nov 16, 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -51.1K -4.44% $0.00 1.1M Nov 12, 2021 Common Stock 51.1K $4.42 Direct F1, F5
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -61.6K -5.6% $0.00 1.04M Nov 15, 2021 Common Stock 61.6K $4.42 Direct F1, F5
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -37.3K -3.6% $0.00 1M Nov 16, 2021 Common Stock 37.3K $4.42 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise price is in U.S. Dollars and reflects the conversion of GBP to USD at an exchange rate of GBP 1.00 to $1.34.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.56 to $12.765, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.03 to $12.615, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F5 One-sixteenth (1/16th) of the shares underlying this option vested on December 7, 2020, and the remainder vested or shall vest monthly in forty-five (45) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.